Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

international health solutions ltd. - tablete

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

vitalize products - cits, šķīstoša tablete

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

šķidrums, aerosols

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

kapsula

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psihoterapija - slenyto ir indicēts, lai ārstētu bezmiegs bērniem un pusaudžiem vecumā 2-18. daļa ar autismu spektra traucējumi (asd) un / vai smits-magenis sindroms, kur gulēt higiēnas pasākumi nav bijuši pietiekami,.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - miega uzsākšanas un uzturēšanas traucējumi - psihoterapija - circadin ir norādīts kā primārais bezmiegs īstermiņa ārstēšanai monoterapijā raksturo zemas kvalitātes miegs, pacientiem, kuri ir vecumā no 55 vai vairāk.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - wet macular degeneration - oftalmoloģiskie līdzekļi - macugen ir indicēts neovaskulārai (mitrai) ar vecumu saistītā makulas deģenerācijai (amd).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitisinone - tyrosinēmijas - citas gremošanas trakta un metabolisma produkti, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumabs - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agents for dermatitis, excluding corticosteroids - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

international health solutions ltd. - kapsula